欧州連合 -
スロベニア語 -
EMA (European Medicines Agency)
rapilysin
actavis group ptc ehf - reteplaza - miokardni infarkt - antitrombotična sredstva - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.